$1.71
-0.058-3.28%
Last update: Nov 6, 5:22 PM
BioLine Rx Ltd (BLRX) Stock Price, Quote, News & History
BLRXNASDAQ
BioLineRx shares new GLIX1 glioblastoma data showing anti-tumor activity, including in temozolomide-resistant cancer models.
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
BioLine Rx has a consensus price target of $19.00.
The stock price for BioLine Rx (NASDAQ: BLRX) is $1.6 last updated November 6, 2026 at 5:22 PM EST.
There are no upcoming dividends for BioLine Rx.
BioLine Rx does not have any upcoming earnings scheduled.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for...
